© 2016, Bayer AS
Siste oppdatering 08 april 2016
L.NO.MKT.03.2016.1478

Events Calendar

Flash is required to view the interactive calendar which can be installed at http://www.adobe.com

Events in detail

2007

EFORT (European Federation of National Associations of Orthopaedics and Traumatology)

event logo
EFORT (11th to 15th May 2007)

8th EFORT Congress

Florence, Italy

The European Federation of Orthopaedics and Traumatology (EFORT) promotes the exchange of scientific knowledge and experience. As a Pan-European organisation, EFORT is recognised as representing an outstanding level of orthopaedics.

 
Xarelto® Programme
Date Event Relevant material Location Time

May 13th

Advances in the surgical and clinical management of orthopaedic patients

The future potential of oral anticoagulation with rivaroxaban — a once-daily, direct Factor Xa inhibitor. Michael Rud Lassen

Michelangelo Room, Fortezza da Basso

12.15–13.45

May 13th

Guidelines for thromboprophylaxis after major orthopaedic surgery

William Geerts

12.15

May 13th

Minimally invasive hip replacement: the MicroHipTM technique

Markus Michel

12.35

May 13th

Evolution of minimally invasive surgery in total joint arthroplasty: learning curves and pitfalls

Louis Kwong

12.50

May 13th

Anticoagulants for use after major orthopaedic surgery: the story so far …

Ander T Cohen

13.05

May 13th

Anticoagulation with rivaroxaban — a novel, oral, direct Factor Xa inhibitor

Bengt Eriksson

13.20

May 13th

Summary

Michael Rud Lassen

13.40

May 13th

Close

13.45

May 13th

The effect of age, gender and weight on the safety and pharmacology of rivaroxaban (BAY 59-7939) – a novel, oral, direct Factor Xa inhibitor

Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Michael Zuehlsdorf

Poster

May 13th

Rivaroxaban – a novel, oral, direct Factor Xa inhibitor – has no clinically relevant interaction with Aspirin or naproxen

Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Michael Zuehlsdorf

Poster

2008

AHA (American Heart Association)

AHA (8-12 November 2008 )

American Heart Association's Scientific Sessions 2008

New Orleans, US

The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.

Xarelto® Programme
Date Event Relevant material Location Time

Nov 10th

Plenary Session: Randomized Comparison of Rivaroxaban, an Oral Direct Factor Xa Inhibitor, with Placebo in Patients with Acute Coronary Syndromes: The ATLAS ACS-TIMI 46 Trial

Michael C. Gibson

New Orleans - Congress Center, Hall F

10:45 - 11 am


ASH (American Society of Hematology)

ASH (6-9 December 2008 )

50th ASH Annual Meeting and Exposition

San Francisco, US

Held annually in December, the Society's annual meeting provides hematologists from around the world a forum for discussing critical issues in hematology.

Xarelto® Programme
Date Event Relevant material Location Time

Dec 5th

CME Symposium - New Perspectives, New Strategies in Venous Thromboembolic Disease

Jeffrey Weitz, Charles T. Esmon, Alexander G.G. Turpie and Richard Joel Friedman

San Francisco Marriott – Yerba Buena Ballroom, Salon 9

6 – 10 pm

Dec 6th

Poster Presentation - Rivaroxaban for Prevention of Venous Thromboembolism after Total Knee Replacement: Impact on Healthcare Costs Based on the RECORD4 Study

Louis Kwong

Moscone Center, Hall A, Poster Board No: I-394

5:30 – 7:30 pm

Dec 6th

Poster Presentation - Will Rivaroxaban be Cost-effective for Prevention of Venous Thromboembolism after Total Hip Replacement in US Patients?

Louis Kwong

Moscone Center, Hall A, Poster Board No: I-395

5:30 – 7:30 pm

Dec 6th

Poster Presentation - Cost-effectiveness of Rivaroxaban as VTE Prophylaxis after Total Hip Replacement in Canada

Philip Wells

Moscone Center, Hall A, Poster Board No: I-396

5:30 – 7:30 pm

Dec 6th

Poster - Indirect Comparisons of Rivaroxaban Versus Alternative Prophylaxes for the Prevention of VTE in Patients Undergoing Total Knee Replacement

Alexander Diamantopoulos

Moscone Center, Hall A, Poster Board No: I-397

Dec 7th

Paper - Once-Daily Oral Rivaroxaban Compared with Subcutaneous Enoxaparin Every 12 Hours for Thromboprophylaxis after Total Knee Replacement: RECORD4

Alexander GG Turpie

Moscone Center

5:30 pm

Dec 7th

Paper - A Pooled Analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effect on Symptomatic Venous Thromboembolism, Death, and Bleeding

Alexander GG Turpie

Moscone Center

5:45 pm

Dec 7th

Poster Presentation - A Pooled-analysis of Four Pivotal Studies of Rivaroxaban for the Prevention of Venous Thromboembolism after Orthopaedic Surgery: Effects of Specified Co-Medications

Bengt Eriksson

Moscone Center, Hall A,Poster Board No: II-80

6 – 8 pm

Dec 8th

Paper - Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients

Bijan Borah

Moscone Center

8:15 am

Dec 8th

Paper - Effects of Age, Weight, Gender and Renal Function in a Pooled Analysis of Four Phase III Studies of Rivaroxaban for Prevention of Venous Thromboembolism after Major Orthopedic Surgery

Kenneth A. Bauer

Moscone Center

2:15 pm

Dec 8th

Paper - Direct Thrombin Inhibitors, but Not Factor Xa Inhibitors, Enhance Thrombin Formation in Human Plasma by Interfering with the Thrombin–Thrombomodulin– Protein C System

Elisabeth Perzborn

Moscone Center

2:45 pm

Dec 8th

Poster Presentation - Potential of Activated Prothrombin Complex Concentrate and Activated Factor VII to Reverse the Anticoagulant Effects of Rivaroxaban in Primates

András Gruber

Moscone Center, Hall A, Poster Board No: III-907

5:30 – 7:30 pm

Dec 8th

Poster - Effects of the Novel, Oral, Direct Factor Xa Inhibitor Rivaroxaban on Coagulation Assays

Meyer Michel Samama

Moscone Center, Hall A, Poster Board No: III-110

Dec 8th

Poster - Improvement of Thrombolysis by Rivaroxaban, An Anti Xa Inhibitor. Potential Therapeutic Importance in Patients with Thrombosis

Remi Varin

Moscone Center, Hall A, Poster Board No: III-113


CHEST (American College of Chest Physicians)

CHEST (25-30 October 2008 )

CHEST 2008

Philadelphia, PA

Recognized around the world as the authority in clinical chest medicine, CHEST 2008 is the one event that can deliver education, experience, expertise.


EFORT (European Federation of National Associations of Orthopaedics and Traumatology)

event logo
EFORT (29 May - 1 June 2008)

9th EFORT Congress

Nice, France

The scientific programme includes symposia and instructional lectures delivered by distinguished speakers from across Europe, free papers, posters, workshops, industry symposia and technical exhibits.

 
Xarelto® Programme
Date Event Relevant material Location Time

May 30th

Improving patient outcomes after major orthopaedic surgery

Bengt Eriksson and Alexander GG Turpie

Nice Acropolis

12:00 - 14:00

May 30th

Introduction

Bengt Eriksson, Sweden

12:15

May 30th

What's new in total hip and knee replacement?

Wolfgang Klauser, Germany

May 30th

Total hip and knee replacement: an anaesthetist's perspective

Nadja Rosencher, France

May 30th

Reducing the risk of VTE after total hip replacement

Ajay Kakkar, UK

May 30th

Reducing the risk of symptomatic VTE after total knee replacement

Michael Rud Lassen, Denmark

May 30th

Summary

Alexander GG Turpie

May 30th

Close

14:00


EHA (European Hematology Association)

EHA (12-15 June 2008 )

13th Congress of the European Hematology Association

Copenhagen, Denmark

The Scientific Program Committee of the European Haematology Association and its Advisory Board have taken much effort to generate a timely and stimulating program covering the broad spectrum of benign and malignant hematology.


ESC (European Society of Cardiology)

ESC (30 August - 3 September 2008 )

ESC Congress 2008

Munich, Germany

The ESC congress provides a unique forum where medical professionals from all around the world have the opportunity to meet and exchange ideas and information in the field of cardiovascular medicine. The theme of this year's congress: cardiovascular imaging.

Xarelto® Programme
Date Event Relevant material Location Time

Sep 1st

Anticoagulant therapy: new perspectives in cardiovascular medicine

The current role of anticoagulants in cardiovascular medicine The need for new oral anticoagulants in clinical practice What can ongoing clinical trials demonstrate? New anticoagulants in developments clinical perspectives C Bode, FWA Verheugt

Oslo- Zone A1

18:30 - 20:00

Welcome and introduction

Christoph Bode, Germany

18:30–18:40

The current role of anticoagulants in cardiovascular medicine

Raffaele de Caterina, Italy

18:40–18:55

The need for new oral anticoagulants in clinical practice

Elaine Hylek, USA

18:55–19:10

What can ongoing clinical trials demonstrate?

Jonathan Halperin, USA

19:10–19:25

New anticoagulants in development: clinical perspectives

Thomas Lüscher, Switzerland

19:25–19:40

Panel and audience discussion

19:40–19:55

Close

Freek Verheugt, The Netherlands

19:55–20:00

02. Sep 08 - Abstract Number: 81940, Poster Session 5 (Number 305), Posters Zone B4

The oral, direct factor Xa inhibitor rivaroxaban prevented right ventricular pressure increase and hypertrophy without increasing bleeding in a pulmonary artery hypertension model in rats Elisabeth Perzborn

03. Sep 08 - Abstract Number: 85236, Poster Session 7 (Number: 307), Posters Zone B4

Hypercoagulability in rats is increased by low doses of the direct thrombin inhibitor melagatran, but is reduced by the direct factor Xa inhibitor rivaroxaban Elisabeth Perzborn

03. Sep 08 - Abstract Number: 86450, Poster Session 7 (Number 307), Posters Zone B4

A meta-analysis of three pivotal studies of rivaroxaban for thromboprophylaxis after orthopaedic surgery: effect on symptomatic venous thromboembolism, all-cause mortality and bleeding Alexander GG Turpie


ICT (International Congress on Thrombosis)

ICT (25–28 June 2008)

20th International Congress on Thrombosis

Athens, Greece

International Thrombosis Congress of MLTD (The Meditteranean League against Thromboembolic Diseases) offers exchange of views and updates on technological advances in the management of Thromboembolic Diseases, as well as new drugs and new therapeutic techniques.

Xarelto® Programme
Date Event Relevant material Location Time

Jun 27th

Key Note Lecture

Reducing the risk of symptomatic VTE after major orthopaedic surgery: learnings from the RECORD programme Sylvia Haas, Germany

Room Terpsichore A, Hilton Hotel

11:00–11:30

Recombinant Factor VIIa reverses the effects of a high dose of rivaroxaban in baboons

Andras Gruber, Ulla M Marzec, Ulf Buetehorn, Stephen R Hanson, Elisabeth Perzborn

Poster

Economic impact of venous thromboprophylaxis with rivaroxaban after major orthopaedic surgery

Michael Lees, Nishan Sengupta

Poster

No interaction between rivaroxaban – a novel, oral, direct Factor Xa inhibitor – and atorvastatin

Dagmar Kubitza, Wolfgang Mueck, Michael Becka

Indirect comparison of rivaroxaban regimens vs standard prophylaxis for the prevention of venous thromboembolism in patients undergoing total hip or total knee replacement

Alexander Diamantopoulos, Corinne LeReun, Farhat Rasul, Michael Lees, Maria Kubin

Poster

FEIBA reverses the effects of a high dose of rivaroxaban in rats

Elisabeth Perzborn, Hanna Tinel

Poster

Relationship between urinary prothrombin fragment 1+2 levels and venous thromboembolic or bleeding events following total hip replacement

Lars C Borris, Morten Breindahl, Michael Rud Lassen, Akos Ferenc Pap, Frank Misselwitz

Poster

Effects of rivaroxaban and fondaparinux on clotting assays

Meyer Michel Samama, Léna Le Flem, Céline Guinet, Elisabeth Perzborn, Jean-Luc Martinoli, François Depasse

Poster

Measuring rivaroxaban pharmacodynamics: prothrombinase-induced clotting time (PiCT®) and Heptest®

Meyer Michel Samama, Léna Le Flem, Céline Guinet, Elisabeth Perzborn, François Depasse

Poster

Concomitant administration of rivaroxaban – an oral, direct Factor Xa inhibitor – with clopidogrel and acetylsalicylic acid enhances antithrombosis in rats

Elisabeth Perzborn, Elke Fischer, Uwe Lange

Poster

Economic burden of venous thromboembolism in the general population and after major orthopaedic surgery – results of a systematic literature review

Thomas Steinle, Andras Ruppert, Michael Lees

Poster


ISPOR (International Society for Pharmacoeconomics and Outcomes Research)

ISPOR (8-11 November 2008)

ISPOR 11th Annual European Congress

Athens, Greece

The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research. ISPOR is organized to act as a scientific leader relevant to research in pharmacoeconomics, health outcomes assessment, and related issues of public policy.

Xarelto® Programme
Date Event Relevant material Location Time

Nov 10th

Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total hip replacement in Spain

Diamantopoulos A

Hilton Athens

8 am - 7:30 pm

Nov 10th

Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total hip replacement in Canada

Diamantopoulos A

Hilton Athens

8 am - 7:30 pm

Nov 10th

Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total knee replacement in the UK and Spain

Diamantopoulos A

Hilton Athens

8 am - 7:30 pm

Nov 10th

Poster - Cost-effectiveness of rivaroxaban versus enoxaparin for thromboprophylaxis after total hip replacement in the UK

Diamantopoulos A

Hilton Athens

8 am - 7:30 pm

Nov 10th

Poster - Prophylaxis with rivaroxaban against venous thromboembolism (VTE): a cost-consequence analysis from the Italian Healthcare Service perspective

Negrini C

Hilton Athens

8 am - 7:30 pm


SSC (International Society on Thrombosis and Haemostasis - Scientific and Standardisation Committee meeting)

SSC (2-5 July 2008)

The 54th Annual Scientific and Standardization Committee Meeting

Vienna, Austria

The purpose of the ISTH's Reach the World Initiative is to foster and support world-wide growth of the field of thrombosis, hemostasis, and vascular biology, particularly in economically developing areas; and to support the next generation of investigators with state-of-the-art knowledge in diseases and disorders of thrombosis, hemostasis and their underlying vascular biology.

Xarelto® Programme
Date Event Relevant material Location Time

Jul 3rd

Rivaroxaban: potential clinical impact of simplified oral anticoagulant thromboprophylaxis

Exciting results are emerging on a novel, oral, direct Factor Xa inhibitor in development, rivaroxaban. Results of extensive phase III clinical trials – the RECORD programme – that have involved over 12,000 patients worldwide demonstrate the benefits of this oral, easy-to-administer anticoagulant for thromboprophylaxis following total knee or hip replacement and the drug’s potential in other indications. Ajay Kakkar, UK and Kenneth A. Bauer, USA

Klimt 2, Hilton Vienna

12:00–13:30

Welcome and introduction

Ajay Kakkar, UK and Kenneth A. Bauer, USA

12:00–12:10

Clinical benefits of rivaroxaban for thromboprophylaxis after total hip replacement

Sylvia Haas, Germany

12:10–12:35

Clinical benefits of rivaroxaban for thromboprophylaxis after total knee replacement

Walter Ageno, Italy

12:35–13:00

Simplifying oral anticoagulation: a clinician’s perspective on rivaroxaban

Gregory Lip, UK

13:00–13:15

Panel and audience discussion

13:15–13:30

Close

13:30

2009

AAOS (American Academy of Orthopaedic Surgeons)

AAOS (25-28 February 2009 )

AAOS 2009 Annual Meeting

Las Vegas, Nevada

The technical exhibits at the AAOS 2009 Annual Meeting, February 25-28, Las Vegas, Nevada, offer you the single, best opportunity to compare products, attend demonstrations and have questions answered by representatives from over 400 companies from around the world.

Xarelto® Programme
Date Event Relevant material Location Time

Feb 27th

Thromboprophylaxis with Rivaroxaban versus Enoxaparin after Total Knee Replacement: RECORD4

Alexander G Turpie, Canada

Venetian Hotel Room 3105

12:18 - 12:24


ACC (American College of Cardiology - 58th Annual Scientific Session)

ACC (29-31 Mar 2009 )

American College of Cardiology - 58th Annual Scientific Session

Orlando, Florida

The ACC Annual Scientific Session is the largest and foremost cardiovascular meeting, offering attainable, reliable and applicable learning solutions that help CV professionals turn cardiovascular knowledge to practice that saves and improves lives.

Xarelto® Programme
Date Event Relevant material Location Time

Apr 27th

Educational Satellite Symposia - Anticoagulant Therapy in the Cardiology Patient: The known, the Unknown, the Unknowable

Peabody Orlando

2:45 pm


ACCP/Chest (American College of Chest Physicians)

ACCP/Chest (31 Oct - 5 Nov 2009)

CHEST 2009

San Diego, California

The American College of Chest Physicians (ACCP) is the world’s largest clinical cardiopulmonary and critical care medical society with more than 17,000 members in 100 countries. Members include physicians, allied health professionals, and PhDs from the specialties of pulmonology, critical care medicine, thoracic surgery, cardiology, sleep, and other chest-related specialties.


AHA (American Heart Association's Scientific Sessions 2009)

AHA (Nov. 14-18 2009)

AHA 2009

Orlando, Florida

The American Heart Association's Scientific Sessions is the premier cardiovascular meeting that offers scientific programming in three broad areas of clinical, basic and population science as well as cross-disciplinary translational science due to the ever-increasing integration of research and patient care.


ASH (American Society of Hematology)

ASH (5–8 Dec 2009)

2009 ASH Annual Meeting

New Orleans, USA

Held annually in December, the Society's annual meeting provides hematologists from around the world a forum for discussing critical issues in hematology.


EAHP (European Association of Hospital Pharmacists)

EAHP (25-27 Mar 2009)

14th congress of the European Association of Hospital Pharmacists

Barcelona, Spain

Entitled "IT and Automation for the Hospitals Pharmacists - tools for better care", the congress will address topics that are at the forefront of the daily work of hospital pharmacists in the field of computerization and technology, in addition to a variety of other subjects for which the EAHP congress has become recognised as one of the premier educational events worldwide in the spring season of each year.

Xarelto® Programme
Date Event Relevant material Location Time

Mar 25th

Satellite Symposium - Thrombosis management: simplified anticoagulation therapy with oral Factor Xa inhibitors

Alexander GG Turpie, Canada Reinhold Kreutz, Germany

Barcelona, Auditorium of the Palacio de Congressos de Catalunya

11:30 am - 1 pm


EFORT (European Federation of National Associations of Orthopaedics and Traumatology)

event logo
EFORT (3-6 June 2009 )

10th EFORT Congress

Vienna, Austria

EFORT’s 10th Anniversary Congress in Vienna. The scientific programme includes symposia and instructional lectures delivered by distinguished speakers from across Europe.

 
Xarelto® Programme
Date Event Relevant material Location Time

Jun 4th

Satellite Symposium - Bayer Schering Pharma - Clot Prevention now a whole lot easier…The role of direct Factor Xa inhibition after elective hip and knee arthroplasty

Lars Borris, Denmark
Wolfgang Klauser, Germany

Austria Center Vienna, Auditorium Room K

12 - 2 pm


EHA (European Hematology Association)

EHA (4-7 June 2009 )

14th Congress of the European Hematology Association

Berlin, Germany

The 14th Congress of the EHA will provide a comprehensive program for clinical and basic hematologists. Important information will be offered in education, scientific, controversial and poster sessions.


ESA (European Society of Anaesthesiology)

ESA (6 – 9 June 2009)

Euroanaesthesia 2009

Italy, Milan

The ESA organises the European Anaesthesiology Congresses throughout Europe under the banner EUROANAESTHESIA. These meetings are attended by members and non-members representing more than 80 countries from around the world. The European Anaesthesiology Congresses offer a comprehensive scientific programme of refresher course lectures, symposia and workshops, together with presentation and discussion of the latest research undertaken in Europe in particular. The European Anaesthesiology Congresses are organised with active participation of the National Societies, and joint meetings are held with them on occasion. The European Anaesthesiology Congresses are accredited by the U.E.M.S./EACCME for C.M.E. credits. More than 100 exhibitors participate in the industrial exhibition at the EUROANAESTHESIA annual meeting.


ESC (European Society of Cardiology)

ESC (29 Aug – 1Sep 2009)

ESC Congress 2009

Barcelona, Spain

The ESC Congress, the largest medical meeting in Europe, is an international meeting and one of the leading events in cardiology.


ESRA (European Society of Regional Anaesthesia & Pain Therapy)

ESRA (9-12 Sept 2009)

XXVIII Annual ESRA Congress

Salzburg, Austria

The XXVIII Annual ESRA Congress, to be held in the beautiful Austrian town of Salzburg, will attract over 1,500 anaesthesiologists, physicians and scientists who use regional anaesthesia for surgery, obstetrics and paediatrics and pain control.


ICNC (International Conference of Non-Invasive Cardiovascular Imaging (ESC))

ICNC (10-13 May 2009 )

International Conference of Non-Invasive Cardiovascular Imaging

Barcelona, Spain

The goal of ICNC9, a joint endeavour between the American Society of Nuclear Cardiology (ASNC), the European Association of Nuclear Medicine (EANM) and the ESC Working Group on Nuclear Cardiology and Cardiac Computed Tomography (ESC), is the emphasis on education and continued growth of cardiac imaging within nuclear cardiology.


ISTH (International Society on Thrombosis and Haemostasis)

ISTH (11-16 Jul 2009 )

55th Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Boston, US

The International Society on Thrombosis and Haemostasis, Inc. is organized and operated exclusively for scientific and educational purposes. Its objectives are to foster and advance science relating to the important medical problems of thrombosis and abnormalities of hemostasis and vascular biology; to provide a forum for discussion of these problems; to encourage research on these problems by scientists of the relevant disciplines; to foster the diffusion and exchange of ideas through scientific meetings and publications; to standardize nomenclature and methods as appropriate and timely.


IUA/MLAVS (XIX Meeting of the Mediterranean League of Angiology and Vascular Surgery)

IUA/MLAVS (19-22 Sept 2009)

XIX MLAVS 2009

Palermo, Italy

The Congress is aiming to present and debate the most recent experiences and researches in the field of vascular pathology between angiologists, cardiologists, diabetologists, specialists in internal medicine and geriatrics, haematologists, radiologists, vascular surgeons as well as young post-graduating doctors in these disciplines and nurses.


SICOT (International Society of Orthopaedic Surgery and Traumatology)

event logo
SICOT (29 Oct – 01 Nov 2009 )

Sixth SICOT/SIROT Annual International Conference

Pattaya, Thailand

A major topic, among many others at the Conference, will be the treatment of degenerative conditions affecting the musculoskeletal system. The longer human life span has made this subject an imperative for the orthopaedic surgeon.